Alaunos Therapeutics
TCRT
#10836
Rank
โ‚น0.45 B
Marketcap
โ‚น187.33
Share price
0.73%
Change (1 day)
-22.89%
Change (1 year)

Revenue for Alaunos Therapeutics (TCRT)

Revenue in 2026 (TTM): โ‚น0.26 Million

According to Alaunos Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น0.28 Million. In 2025 the company made a revenue of โ‚น0.44 Million a decrease over the revenue in the year 2024 that were of โ‚น0.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alaunos Therapeutics from 2001 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น0.26 M-40%
2025 โ‚น0.44 M-41.87%
2024 โ‚น0.77 M85.49%
2023 โ‚น0.41 M-99.83%
2022 โ‚น0.24 B716.23%
2021 โ‚น29.62 M
2020 N/A
2019 N/A-100%
2018 โ‚น10.2 M-97.5%
2017 โ‚น0.40 B-12.5%
2016 โ‚น0.46 B61.95%
2015 โ‚น0.28 B230.83%
2014 โ‚น87.01 M76.06%
2013 โ‚น49.42 M12.83%
2012 โ‚น43.8 M24.14%
2011 โ‚น35.28 M
2010 N/A
2009 N/A
2002 โ‚น0.12 M47.98%
2001 โ‚น0.08 M